Mark Frederick Mccarty

Mark Frederick Mccarty's AcademicInfluence.com Rankings

Biology

#6535

World Rank

#9271

Historical Rank

Molecular Biology

#680

World Rank

#697

Historical Rank

Biochemistry

#843

World Rank

#950

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Mark Frederick Mccarty Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mark Frederick Mccarty's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. (2003) (287)
Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. (1999) (254)
Clinical potential of Spirulina as a source of phycocyanobilin. (2007) (200)
Phycocyanin and phycocyanobilin from Spirulina platensis protect against diabetic nephropathy by inhibiting oxidative stress. (2013) (181)
Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy (2004) (168)
A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk. (2005) (159)
Manipulating tumor acidification as a cancer treatment strategy. (2010) (154)
Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. (2006) (145)
''Iatrogenic Gilbert syndrome''--a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. (2007) (135)
Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus (2020) (122)
Vegan proteins may reduce risk of cancer, obesity, and cardiovascular disease by promoting increased glucagon activity. (1999) (111)
Should we restrict chloride rather than sodium? (2004) (109)
The low-methionine content of vegan diets may make methionine restriction feasible as a life extension strategy. (2009) (109)
Capsaicin may have important potential for promoting vascular and metabolic health (2015) (101)
Proposal for a dietary "phytochemical index". (2004) (98)
Nutraceutical resources for diabetes prevention--an update. (2005) (91)
Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders. (2006) (91)
Preadministration of High-Dose Salicylates, Suppressors of NF-κB Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation Therapy (2006) (90)
Pentoxifylline for vascular health: a brief review of the literature (2016) (84)
Chronic activation of AMP-activated kinase as a strategy for slowing aging. (2004) (83)
Parathyroid hormone may be a cancer promoter - an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D. (2000) (80)
Promotion of hepatic lipid oxidation and gluconeogenesis as a strategy for appetite control. (1994) (79)
High-dose pyridoxine as an 'anti-stress' strategy. (2000) (76)
Up-regulation of IGF binding protein-1 as an anticarcinogenic strategy: relevance to caloric restriction, exercise, and insulin sensitivity. (1997) (75)
Magnesium may mediate the favorable impact of whole grains on insulin sensitivity by acting as a mild calcium antagonist. (2005) (71)
The neglect of glucosamine as a treatment for osteoarthritis--a personal perspective. (1994) (69)
Lauric acid-rich medium-chain triglycerides can substitute for other oils in cooking applications and may have limited pathogenicity (2016) (69)
Induction of heat shock proteins may combat insulin resistance. (2006) (66)
Increased homocyst(e)ine associated with smoking, chronic inflammation, and aging may reflect acute-phase induction of pyridoxal phosphatase activity. (2000) (65)
Glucosamine for wound healing. (1996) (65)
A paradox resolved: the postprandial model of insulin resistance explains why gynoid adiposity appears to be protective. (2003) (63)
An increased need for dietary cysteine in support of glutathione synthesis may underlie the increased risk for mortality associated with low protein intake in the elderly (2015) (62)
Secondary hyperparathyroidism promotes the acute phase response -- a rationale for supplemental vitamin D in prevention of vascular events in the elderly. (2005) (60)
Coenzyme Q10 for the treatment of heart failure: a review of the literature (2015) (58)
High-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetes. (1999) (58)
Fish oil may impede tumour angiogenesis and invasiveness by down-regulating protein kinase C and modulating eicosanoid production. (1996) (58)
The Molecular Biology and Pathophysiology of Vascular Calcification (2014) (55)
Thalidomide may impede cell migration in primates by down-regulating integrin beta-chains: potential therapeutic utility in solid malignancies, proliferative retinopathy, inflammatory disorders, neointimal hyperplasia, and osteoporosis. (1997) (52)
Enhanced synovial production of hyaluronic acid may explain rapid clinical response to high-dose glucosamine in osteoarthritis. (1998) (52)
Zinc and multi-mineral supplementation should mitigate the pathogenic impact of cadmium exposure. (2012) (50)
Activation of PPARgamma may mediate a portion of the anticancer activity of conjugated linoleic acid. (2000) (50)
Polyphenol-mediated inhibition of AP-1 transactivating activity may slow cancer growth by impeding angiogenesis and tumor invasiveness. (1998) (49)
The origins of western obesity: a role for animal protein? (2000) (49)
Anabolic effects of insulin on bone suggest a role for chromium picolinate in preservation of bone density. (1995) (48)
Homologous physiological effects of phenformin and chromium picolinate. (1993) (48)
Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen. (2002) (48)
Glucomannan minimizes the postprandial insulin surge: a potential adjuvant for hepatothermic therapy. (2002) (47)
Potential clinical applications for high-dose nutritional antioxidants. (1984) (47)
Up-regulation of endothelial nitric oxide activity as a central strategy for prevention of ischemic stroke - just say NO to stroke! (2000) (47)
Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase (2020) (46)
Regular thermal therapy may promote insulin sensitivity while boosting expression of endothelial nitric oxide synthase--effects comparable to those of exercise training. (2009) (45)
The chlorophyll metabolite phytanic acid is a natural rexinoid--potential for treatment and prevention of diabetes. (2001) (44)
Modulation of adipocyte lipoprotein lipase expression as a strategy for preventing or treating visceral obesity. (2001) (43)
Oral phycocyanobilin may diminish the pathogenicity of activated brain microglia in neurodegenerative disorders. (2010) (43)
Sulfated glycosaminoglycans and glucosamine may synergize in promoting synovial hyaluronic acid synthesis. (2000) (43)
Dietary Glycine Is Rate-Limiting for Glutathione Synthesis and May Have Broad Potential for Health Protection. (2018) (43)
Up-regulatory impact of boron on vitamin D function -- does it reflect inhibition of 24-hydroxylase? (2004) (41)
High-dose folate and dietary purines promote scavenging of peroxynitrite-derived radicals--clinical potential in inflammatory disorders. (2009) (40)
Toward prevention of Alzheimers disease--potential nutraceutical strategies for suppressing the production of amyloid beta peptides. (2006) (40)
Hyperinsulinemia may boost both hematocrit and iron absorption by up-regulating activity of hypoxia-inducible factor-1alpha. (2003) (39)
Ketosis may promote brain macroautophagy by activating Sirt1 and hypoxia-inducible factor-1. (2015) (39)
Up-regulation of intracellular signalling pathways may play a central pathogenic role in hypertension, atherogenesis, insulin resistance, and cancer promotion--the 'PKC syndrome'. (1996) (38)
Enhancing central and peripheral insulin activity as a strategy for the treatment of endogenous depression--an adjuvant role for chromium picolinate? (1994) (38)
omega-3 Fatty acids infusions as adjuvant therapy in rheumatoid arthritis. (2010) (38)
Nitric oxide deficiency, leukocyte activation, and resultant ischemia are crucial to the pathogenesis of diabetic retinopathy/neuropathy--preventive potential of antioxidants, essential fatty acids, chromium, ginkgolides, and pentoxifylline. (1998) (38)
Does a vegan diet reduce risk for Parkinson's disease? (2001) (38)
Insulin secretion as a potential determinant of homocysteine levels. (2000) (38)
Serum bilirubin may serve as a marker for increased heme oxygenase activity and inducibility in tissues--a rationale for the versatile health protection associated with elevated plasma bilirubin. (2013) (38)
Boosting endogenous production of vasoprotective hydrogen sulfide via supplementation with taurine and N-acetylcysteine: a novel way to promote cardiovascular health (2017) (37)
Vascular nitric oxide may lessen Alzheimer's risk. (1998) (37)
The reported clinical utility of taurine in ischemic disorders may reflect a down-regulation of neutrophil activation and adhesion. (1999) (37)
Complementary vascular-protective actions of magnesium and taurine: a rationale for magnesium taurate. (1996) (36)
Acid-base balance may influence risk for insulin resistance syndrome by modulating cortisol output. (2005) (36)
Current prospects for controlling cancer growth with non-cytotoxic agents--nutrients, phytochemicals, herbal extracts, and available drugs. (2001) (36)
Can correction of sub-optimal coenzyme Q status improve beta-cell function in type II diabetics? (1999) (35)
Elevated sympathetic activity may promote insulin resistance syndrome by activating alpha-1 adrenergic receptors on adipocytes. (2004) (35)
The low-AGE content of low-fat vegan diets could benefit diabetics - though concurrent taurine supplementation may be needed to minimize endogenous AGE production. (2005) (35)
PKC-mediated modulation of L-type calcium channels may contribute to fat-induced insulin resistance. (2006) (35)
AMPK activation as a strategy for reversing the endothelial lipotoxicity underlying the increased vascular risk associated with insulin resistance syndrome. (2005) (35)
Toward practical prevention of type 2 diabetes. (2000) (34)
Omega-3s and cardiovascular health. (2014) (34)
Coenzyme Q versus hypertension: does CoQ decrease endothelial superoxide generation? (1999) (34)
Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians. (2009) (34)
Inhibition of acetyl-CoA carboxylase by cystamine may mediate the hypotriglyceridemic activity of pantethine. (2001) (34)
Does bitter melon contain an activator of AMP-activated kinase? (2004) (33)
Scavenging of peroxynitrite-derived radicals by flavonoids may support endothelial NO synthase activity, contributing to the vascular protection associated with high fruit and vegetable intakes. (2008) (33)
The hyperpolarizing impact of glycine on endothelial cells may be anti-atherogenic. (2009) (33)
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19 (2020) (33)
Versatile cytoprotective activity of lipoic acid may reflect its ability to activate signalling intermediates that trigger the heat-shock and phase II responses. (2001) (32)
Up-regulation of PPARγ coactivator-1α as a strategy for preventing and reversing insulin resistance and obesity (2005) (32)
Metformin may antagonize Lin28 and/or Lin28B activity, thereby boosting let-7 levels and antagonizing cancer progression. (2012) (32)
mTORC1 activity as a determinant of cancer risk--rationalizing the cancer-preventive effects of adiponectin, metformin, rapamycin, and low-protein vegan diets. (2011) (31)
A central role for protein kinase C overactivity in diabetic glomerulosclerosis: implications for prevention with antioxidants, fish oil, and ACE inhibitors. (1998) (31)
Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic insulin resistance (2019) (31)
Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction. (2004) (31)
GCN2 and FGF21 are likely mediators of the protection from cancer, autoimmunity, obesity, and diabetes afforded by vegan diets. (2014) (30)
Mortality from Western cancers rose dramatically among African-Americans during the 20th century: are dietary animal products to blame? (2001) (30)
DL-phenylalanine markedly potentiates opiate analgesia - an example of nutrient/pharmaceutical up-regulation of the endogenous analgesia system. (2000) (30)
Ferulic acid may target MyD88-mediated pro-inflammatory signaling - Implications for the health protection afforded by whole grains, anthocyanins, and coffee. (2018) (30)
Minimizing the cancer-promotional activity of cox-2 as a central strategy in cancer prevention. (2012) (30)
Nutraceutical Strategies for Suppressing NLRP3 Inflammasome Activation: Pertinence to the Management of COVID-19 and Beyond (2020) (30)
A two-phase strategy for treatment of oxidant-dependent cancers. (2007) (30)
The "rejuvenatory" impact of lipoic acid on mitochondrial function in aging rats may reflect induction and activation of PPAR-gamma coactivator-1alpha. (2009) (30)
Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1 (2015) (29)
Potential utility of natural polyphenols for reversing fat-induced insulin resistance. (2005) (28)
Upregulation of lymphocyte apoptosis as a strategy for preventing and treating autoimmune disorders: a role for whole-food vegan diets, fish oil and dopamine agonists. (2001) (28)
Insulin secretion as a determinant of pancreatic cancer risk. (2001) (28)
Optimizing exercise for fat loss. (1995) (28)
AMPK activation—protean potential for boosting healthspan (2014) (28)
Practical prevention of cardiac remodeling and atrial fibrillation with full-spectrum antioxidant therapy and ancillary strategies. (2010) (27)
Magnesium taurate and fish oil for prevention of migraine. (1996) (27)
Insulin and IGF-I as determinants of low "Western" cancer rates in the rural third world. (2004) (27)
Endothelial membrane potential regulates production of both nitric oxide and superoxide--a fundamental determinant of vascular health. (1999) (27)
The cardiometabolic benefits of glycine: Is glycine an ‘antidote’ to dietary fructose? (2014) (27)
Oxidants downstream from superoxide inhibit nitric oxide production by vascular endothelium--a key role for selenium-dependent enzymes in vascular health. (1999) (27)
Nutraceutical strategies for ameliorating the toxic effects of alcohol. (2013) (26)
Nutraceuticals Targeting Generation and Oxidant Activity of Peroxynitrite May Aid Prevention and Control of Parkinson’s Disease (2020) (26)
Supplemental creatine may decrease serum homocysteine and abolish the homocysteine 'gender gap' by suppressing endogenous creatine synthesis. (2001) (26)
L-carnitine for the treatment of acute myocardial infarction. (2014) (26)
Full-spectrum antioxidant therapy featuring astaxanthin coupled with lipoprivic strategies and salsalate for management of non-alcoholic fatty liver disease. (2011) (26)
Sub-optimal taurine status may promote platelet hyperaggregability in vegetarians. (2004) (25)
Longevity effect of chromium picolinate--'rejuvenation' of hypothalamic function? (1994) (25)
Glucosamine may retard atherogenesis by promoting endothelial production of heparan sulfate proteoglycans. (1997) (25)
Adjuvant strategies for prevention of glomerulosclerosis. (2006) (25)
Reduction of free fatty acids may ameliorate risk factors associated with abdominal obesity. (1995) (25)
Oxidative stress therapy for solid tumors - a proposal. (2010) (25)
Suppression of dolichol synthesis with isoprenoids and statins may potentiate the cancer-retardant efficacy of IGF-I down-regulation. (2001) (24)
Toward a Core Nutraceutical Program for Cancer Management (2006) (24)
Niacinamide therapy for osteoarthritis--does it inhibit nitric oxide synthase induction by interleukin 1 in chondrocytes? (1999) (24)
Genistein and phycocyanobilin may prevent hepatic fibrosis by suppressing proliferation and activation of hepatic stellate cells. (2009) (24)
β-Alanine and orotate as supplements for cardiac protection (2014) (23)
Complementary measures for promoting insulin sensitivity in skeletal muscle. (1998) (23)
Inhibition of citrate lyase may aid aerobic endurance. (1995) (23)
cGMP may have trophic effects on beta cell function comparable to those of cAMP, implying a role for high-dose biotin in prevention/treatment of diabetes. (2006) (23)
Exploiting complementary therapeutic strategies for the treatment of type II diabetes and prevention of its complications. (1997) (23)
Salsalate may have broad utility in the prevention and treatment of vascular disorders and the metabolic syndrome. (2010) (23)
Neuroprotective potential of high-dose biotin. (2017) (23)
Practical strategies for suppressing hypoxia-inducible factor activity in cancer therapy. (2010) (23)
Toward a wholly nutritional therapy for type 2 diabetes. (2000) (22)
Potential complementarity of high-flavanol cocoa powder and spirulina for health protection. (2010) (22)
Antioxidant bilirubin works in multiple ways to reduce risk for obesity and its health complications (2018) (22)
Inhibition of CYP2E1 with natural agents may be a feasible strategy for minimizing the hepatotoxicity of ethanol. (2001) (22)
Reported anti atherosclerotic activity of silicon may reflect increased endothelial synthesis of heparan sulfate proteoglycans (1997) (21)
Bioavailable dietary phosphate, a mediator of cardiovascular disease, may be decreased with plant-based diets, phosphate binders, niacin, and avoidance of phosphate additives. (2014) (21)
Vascular nitric oxide, sex hormone replacement, and fish oil may help to prevent Alzheimer's disease by suppressing synthesis of acute-phase cytokines. (1999) (21)
AMPK activation may suppress hepatic production of C-reactive protein by stimulating nitric oxide synthase. (2004) (21)
A diet rich in taurine, cysteine, folate, B12 and betaine may lessen risk for Alzheimer's disease by boosting brain synthesis of hydrogen sulfide. (2019) (21)
AMP-activated kinase may suppress NADPH oxidase activation in vascular tissues. (2009) (21)
Activation of AMP-activated kinase as a strategy for managing autosomal dominant polycystic kidney disease. (2009) (21)
Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin—Potential for Preventing or Slowing the Progression of Diabetic Complications (2017) (20)
Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality—Should Patients with Elevated Levels Be Supplemented with Citrulline? (2016) (20)
A Higher Dietary Ratio of Long-Chain Omega-3 to Total Omega-6 Fatty Acids for Prevention of COX-2-Dependent Adenocarcinomas (2014) (20)
The therapeutic potential of glucose tolerance factor. (1980) (20)
Increasing Superoxide Production and the Labile Iron Pool in Tumor Cells may Sensitize Them to Extracellular Ascorbate (2014) (20)
Co-administration of equimolar doses of betaine may alleviate the hepatotoxic risk associated with niacin therapy. (2000) (20)
Nutritional modulation of parathyroid hormone secretion may influence risk for left ventricular hypertrophy. (2005) (20)
Practical strategies for targeting NF-kappaB and NADPH oxidase may improve survival during lethal influenza epidemics. (2010) (20)
Does postprandial storage of triglycerides in endothelial cells contribute to the endothelial dysfunction associated with insulin resistance and fatty diets? (2003) (19)
Glucosamine for the Treatment of Osteoarthritis: The Time Has Come for Higher-Dose Trials (2019) (19)
Role of dietary histidine in the prevention of obesity and metabolic syndrome (2018) (19)
Pyruvate and hydroxycitrate/carnitine may synergize to promote reverse electron transport in hepatocyte mitochondria, effectively 'uncoupling' the oxidation of fatty acids. (1999) (19)
Favorable impact of a vegan diet with exercise on hemorheology: implications for control of diabetic neuropathy. (2002) (19)
Expression and/or activity of the SVCT2 ascorbate transporter may be decreased in many aggressive cancers, suggesting potential utility for sodium bicarbonate and dehydroascorbic acid in cancer therapy. (2013) (19)
Up-regulation of PPARgamma coactivator-1alpha as a strategy for preventing and reversing insulin resistance and obesity. (2005) (19)
Multifocal Angiostatic Therapy: An Update (2005) (19)
Thalidomide for autoimmune disease. (1983) (19)
Does regular ethanol consumption promote insulin sensitivity and leanness by stimulating AMP-activated protein kinase? (2001) (19)
Fish oil may be an antidote for the cardiovascular risk of smoking. (1996) (19)
Optimizing endothelial nitric oxide activity may slow endothelial aging. (2004) (19)
An elevation of triglycerides reflecting decreased triglyceride clearance may not be pathogenic -- relevance to high-carbohydrate diets. (2004) (18)
Reduction of serum C-reactive protein by statin therapy may reflect decreased isoprenylation of Rac-1, a mediator of the IL-6 signal transduction pathway. (2003) (18)
Hemostatic concomitants of syndrome X. (1995) (18)
The insulin-sensitizing activity of moderate alcohol consumption may promote leanness in women. (2000) (18)
NADPH Oxidase Activity in Cerebral Arterioles Is a Key Mediator of Cerebral Small Vessel Disease—Implications for Prevention (2015) (18)
Autophagy-induced degradation of Notch1, achieved through intermittent fasting, may promote beta cell neogenesis: implications for reversal of type 2 diabetes (2019) (17)
Pre-exercise administration of yohimbine may enhance the efficacy of exercise training as a fat loss strategy by boosting lipolysis. (2002) (17)
Red Yeast Rice Plus Berberine: Practical Strategy for Promoting Vascular and Metabolic Health. (2015) (17)
Point of view--a role for "nutritional insurance" supplementation in preventive medicine. (1981) (17)
ACE inhibition may decrease diabetes risk by boosting the impact of bradykinin on adipocytes. (2003) (17)
Potential utility of full-spectrum antioxidant therapy, citrulline, and dietary nitrate in the management of sickle cell disease. (2010) (17)
Fish oil and other nutritional adjuvants for treatment of congestive heart failure. (1996) (17)
Vitamin D status and muscle strength. (2002) (17)
A low-fat, whole-food vegan diet, as well as other strategies that down-regulate IGF-I activity, may slow the human aging process. (2003) (16)
Practical strategies for modulating foam cell formation and behavior. (2014) (16)
The putative therapeutic value of high-dose selenium in proliferative retinopathies may reflect down-regulation of VEGF production by the hypoxic retina. (2005) (16)
Insulin's stimulation of endothelial superoxide generation may reflect up-regulation of isoprenyl transferase activity that promotes rac translocation. (2002) (16)
An antithrombotic role for nutritional antioxidants: implications for tumor metastasis and other pathologies. (1986) (16)
Perspective: Prospects for Nutraceutical Support of Intestinal Barrier Function. (2020) (15)
The alcohol paradox. (1999) (15)
Dietary saturate/unsaturate ratio as a determinant of adiposity. (2010) (15)
Oster rediscovered--mega-dose folate for symptomatic atherosclerosis. (2007) (15)
Chromium and other insulin sensitizers may enhance glucagon secretion: implications for hypoglycemia and weight control. (1996) (15)
PPAR gamma agonists can be expected to potentiate the efficacy of metronomic chemotherapy through CD36 up-regulation. (2008) (15)
Rationales for micronutrient supplementation in diabetes. (1984) (15)
Insulin resistance--not hyperinsulinemia--is pathogenic in essential hypertension. (1994) (15)
Coping with endothelial superoxide: potential complementarity of arginine and high-dose folate. (2004) (15)
Clinical potential of phycocyanobilin for induction of T regulatory cells in the management of inflammatory disorders. (2011) (15)
C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19-induced Damage to the Nervous System (2021) (15)
Flavones and flavonols may have clinical potential as CK2 inhibitors in cancer therapy. (2020) (14)
A taurine-supplemented vegan diet may blunt the contribution of neutrophil activation to acute coronary events. (2004) (14)
A proposal for the locus of metformin's clinical action: potentiation of the activation of pyruvate kinase by fructose-1,6-diphosphate. (1999) (14)
A role for cAMP-driven transactivation of EGFR in cancer aggressiveness - therapeutic implications. (2014) (14)
Beneficial effects of phycobiliproteins from Spirulina maxima in a preeclampsia model (2018) (14)
Hepatothermic therapy of obesity: rationale and an inventory of resources. (2001) (14)
Androgenic progestins amplify the breast cancer risk associated with hormone replacement therapy by boosting IGF-I activity. (2001) (14)
Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure (2021) (14)
Potential ghrelin-mediated benefits and risks of hydrogen water. (2015) (14)
Omega-3 and prostate cancer: examining the pertinent evidence. (2014) (14)
In type 1 diabetics, high-dose biotin may compensate for low hepatic insulin exposure, promoting a more normal expression of glycolytic and gluconeogenic enyzymes and thereby aiding glycemic control. (2016) (14)
Gamma-tocopherol may promote effective no synthase function by protecting tetrahydrobiopterin from peroxynitrite. (2007) (13)
L-carnitine consumption, its metabolism by intestinal microbiota, and cardiovascular health. (2013) (13)
Ferulic acid and berberine, via Sirt1 and AMPK, may act as cell cleansing promoters of healthy longevity (2022) (13)
A "mini-fast with exercise" protocol for fat loss. (2009) (13)
Orthomolecular aids for dieting. (1982) (13)
Chromium(III) picolinate (1996) (13)
A moderately low phosphate intake may provide health benefits analogous to those conferred by UV light - a further advantage of vegan diets. (2003) (13)
Minimizing Membrane Arachidonic Acid Content as a Strategy for Controlling Cancer: A Review (2018) (12)
Glucosamine in osteoarthritis (1999) (12)
Low-insulin-response diets may decrease plasma C-reactive protein by influencing adipocyte function. (2005) (12)
Melatonin may decrease risk for and aid treatment of COVID-19 and other RNA viral infections (2021) (12)
Supplementary taurine may stabilize atheromatous plaque by antagonizing the activation of metalloproteinases by hypochlorous acid. (2004) (11)
A Fundamental Role for Oxidants and Intracellular Calcium Signals in Alzheimer’s Pathogenesis—And How a Comprehensive Antioxidant Strategy May Aid Prevention of This Disorder (2021) (11)
Utility of metformin as an adjunct to hydroxycitrate/carnitine for reducing body fat in diabetics. (1998) (11)
High mitochondrial redox potential may promote induction and activation of UCP2 in hepatocytes during hepatothermic therapy. (2005) (11)
IGF-I activity may be a key determinant of stroke risk--a cautionary lesson for vegans. (2003) (11)
The ‘ ‘ rejuvenatory ” impact of lipoic acid on mitochondrial function in aging rats may reflect induction and activation of PPAR-c coactivator-1 a (2008) (10)
Glucosamine for migraine prophylaxis? (2000) (10)
Promotion of interleukin-2 activity as a strategy for 'rejuvenating' geriatric immune function. (1997) (10)
An ezetimibe-policosanol combination has the potential to be an OTC agent that could dramatically lower LDL cholesterol without side effects. (2005) (10)
Turning an 'Achilles' Heel' into an asset--activation of HIF-1alpha during angiostatic therapy will increase tumor sensitivity to iron-catalyzed oxidative damage. (2003) (10)
Can moderate elevations of parathyroid hormone acutely increase risk for ischemic cardiac arrhythmias? (2009) (10)
Rationale for a novel immunotherapy of cancer with allogeneic lymphocyte infusion. (1984) (10)
Dietary Glycemic Index May Influence Cancer Risk by Modulating IGF-I Activity: A Hypothesis (1998) (10)
A wholly nutritional 'multifocal angiostatic therapy' for control of disseminated cancer. (2003) (10)
The moderate essential amino acid restriction entailed by low-protein vegan diets may promote vascular health by stimulating FGF21 secretion (2017) (10)
Low Risk of Parkinson's Disease in Quasi-Vegan Cultures May Reflect GCN2-Mediated Upregulation of Parkin. (2020) (10)
Nutritional support of central catecholaminergic tone may aid smoking withdrawal. (1982) (9)
A preliminary fast may potentiate response to a subsequent low-salt, low-fat vegan diet in the management of hypertension - fasting as a strategy for breaking metabolic vicious cycles. (2003) (9)
Insulin resistance in Mexican Americans--a precursor to obesity and diabetes? (1993) (9)
Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors (2021) (9)
Estrogen agonists/antagonists may down-regulate growth hormone signaling in hepatocytes--an explanation for their impact on IGF-I, IGFBP-1, and lipoprotein(a). (2003) (9)
An expanded concept of "insurance" supplementation--broad-spectrum protection from cardiovascular disease. (1981) (9)
Central insulin may up-regulate thyroid activity by suppressing neuropeptide Y release in the paraventricular nucleus. (1995) (9)
Nutraceutical induction and mimicry of heme oxygenase activity as a strategy for controlling excitotoxicity in brain trauma and ischemic stroke: focus on oxidative stress (2020) (9)
Targeting Casein kinase 2 with quercetin or enzymatically modified isoquercitrin as a strategy for boosting the type 1 interferon response to viruses and promoting cardiovascular health. (2020) (9)
Supplemental arginine and high-dose folate may promote bone health by supporting the activity of endothelial-type nitric oxide synthase in bone. (2005) (9)
Marinobufagenin and cyclic strain may activate endothelial NADPH oxidase, contributing to the adverse impact of salty diets on vascular and cerebral health. (2012) (9)
Vitamin D, parathyroid hormone, and insulin sensitivity. (2004) (8)
High-dose folate may improve platelet function in acute coronary syndrome and other pathologies associated with increased platelet oxidative stress. (2007) (8)
A shift in myocardial substrate, improved endothelial function, and diminished sympathetic activity may contribute to the anti-anginal impact of very-low-fat diets. (2004) (8)
Homologous physiological effects of nutritional antioxidants and eicosapentaenoic acid. (1987) (8)
De novo synthesis of diacylglycerol in endothelium may mediate the association between PAI-1 and the insulin resistance syndrome. (2005) (8)
Activated glycine receptors may decrease endosomal NADPH oxidase activity by opposing ClC-3-mediated efflux of chloride from endosomes. (2019) (8)
Vascular heparan sulfates may limit the ability of leukocytes to penetrate the endothelial barrier--implications for use of glucosamine in inflammatory disorders. (1998) (8)
Beyond Androgen Deprivation (2014) (8)
Trimethylamine-N-Oxide and Heart Failure. (2015) (8)
Prospects for glycerol-rescued hypoglycemia as a cancer therapy. (2001) (8)
Subtoxic intracellular trivalent chromium is not mutagenic: implications for safety of chromium supplementation. (1997) (8)
The second phase of brain trauma can be controlled by nutraceuticals that suppress DAMP-mediated microglial activation (2021) (8)
The unique merits of a low-fat diet for weight control. (1986) (8)
Synergistic denaturant therapy--a general strategy for treatment of solid malignancies. (1980) (8)
Reported antiatherosclerotic activity of silicon may reflect increased endothelial synthesis of heparan sulfate proteoglycans. (1997) (8)
Preclinical Studies Suggest Complex Nutraceutical Strategies May Have Potential for Preventing and Managing Sepsis. (2015) (7)
NADPH oxidase mediates glucolipotoxicity-induced beta cell dysfunction--clinical implications. (2010) (7)
Carvedilol and spirulina may provide important health protection to smokers and other nicotine addicts: a call for pertinent research. (2015) (7)
Prenatal high-dose pyridoxine may prevent hypertension and syndrome X in-utero by protecting the fetus from excess glucocorticoid activity. (2000) (7)
Primary open-angle glaucoma may be a hyaluronic acid deficiency disease: potential for glucosamine in prevention and therapy. (1998) (7)
Selenium, calcium channel blockers, and cancer risk--the Yin and Yang of apoptosis? (1998) (7)
Cimetidine as an adjuvant for allogeneic lymphocyte immunotherapy of cancer. (1985) (6)
Dietary nitrate and reductive polyphenols may potentiate the vascular benefit and alleviate the ulcerative risk of low-dose aspirin. (2013) (6)
Concurrent treatment with an ACE inhibitor may amplify the utility of calcium supplementation for control of hypertension. (2004) (6)
Prospects for nutritional control of hypertension. (1981) (6)
Flavones and Flavonols may have Clinical Potential as CK2 Inhibitors in Cancer Therapy (2015) (6)
Chromium meta-analysis. (2003) (6)
natural antimutagenic agents may prolong efficacy of human immunodeficiency virus drug therapy. (1997) (6)
Magnesium taurate for the prevention and treatment of pre-eclampsia/eclampsia. (1996) (6)
Over-the-Counter Chromium and Renal Failure (1997) (6)
Practical prospects for boosting hepatic production of the “pro-longevity” hormone FGF21 (2017) (6)
Is interleukin-6 the link between low LDL cholesterol and increased non-cardiovascular mortality in the elderly? (2018) (6)
Aldosterone and the Gerson diet -- a speculation. (1981) (6)
High Intakes of Bioavailable Phosphate May Promote Systemic Oxidative Stress and Vascular Calcification by Boosting Mitochondrial Membrane Potential—Is Good Magnesium Status an Antidote? (2021) (6)
Hepatic monitoring of essential amino acid availability may regulate IGF-I activity, thermogenesis, and fatty acid oxidation/synthesis. (2001) (6)
Exenatide and biotin in conjunction with a protein-sparing fast for normalization of beta cell function in type 2 diabetics. (2007) (6)
Glucosamine for psoriasis? (1997) (6)
Incorporation of beta cell redifferentiation therapy into a lipoprivic strategy for reversing type 2 diabetes. (2002) (6)
Are organically grown foods safer and more healthful than conventionally grown foods? (2014) (6)
A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis (2021) (5)
Iatrogenic lipodystrophy in HIV patients - the need for very-low-fat diets. (2003) (5)
Vaccination with heat-shocked mononuclear cells as a strategy for treating neurodegenerative disorders driven by microglial inflammation. (2013) (5)
Review – Nutraceuticals Can Target Asthmatic Bronchoconstriction: NADPH Oxidase-Dependent Oxidative Stress, RhoA and Calcium Dynamics (2021) (5)
Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat the Mitochondrial Dysfunction Driving Progression of Dry Age-Related Macular Degeneration (2022) (5)
Neuroprotective potential of the Bahadori leanness program: a "mini-fast with exercise" strategy. (2007) (5)
Rationale for a novel nutraceutical complex 'K-water': potassium taurine bicarbonate (PTB). (2006) (5)
Angiotensin antagonist drugs as “source antioxidants” – down-regulation of NADPH oxidase activation mediates many of their protective benefits, independent of hypertension control - (2015) (5)
Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceuticals: A Practical Strategy for Preserving Bone Mass (2022) (5)
Nutritional prevention of pre-eclampsia--a special role for 1 series prostaglandin precursors? (1982) (5)
Maturity-onset diabetes mellitus--toward a physiological appropriate management. (1981) (5)
Toward a "bio-energy supplement" -- a prototype for functional orthomolecular supplementation. (1981) (5)
Cytostatic and reverse-transforming therapies of cancer - a brief review and future prospects. (1982) (5)
Marinobufagenin may mediate the impact of salty diets on left ventricular hypertrophy by disrupting the protective function of coronary microvascular endothelium. (2004) (5)
Low-Glycotoxin Diets and Spirulina may have Potential for Slowing the Growth and Spread of Rage-expressing Cancers (2014) (4)
Azithromycin and glucosamine may amplify the type 1 interferon response to RNA viruses in a complementary fashion (2020) (4)
A practical prescription for cancer prevention--synergistic use of chemopreventive agents. (1984) (4)
Do omega-3 fatty acids cause prostate cancer? (2013) (4)
The protection conferred by chelation therapy in post-MI diabetics might be replicated by high-dose zinc supplementation. (2015) (4)
Chromium and insulin. (1982) (4)
Nutraceutical and Dietary Strategies for Up-Regulating Macroautophagy (2022) (4)
Lower bioavailability of plant-derived phosphorus. (2014) (4)
Plant-based diets relatively low in bioavailable phosphate and calcium may aid prevention and control of prostate cancer by lessening production of fibroblast growth factor 23. (2017) (4)
Does supplemental creatine prevent herpes recurrences? (2001) (4)
Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone Metastases (2016) (4)
The Ability of Carnitine to Act as a Type 1Histone Deacetylase Inhibitor May Explain the Favorable Impact of Carnitine Supplementation on Mitochondrial Biogenesis in the Elderly (2020) (4)
Eicosapentaenoic acid as an adjuvant to dieting strategies that disinhibit hepatic fatty acid oxidation. (1998) (4)
Dairy products and insulin resistance. (2002) (4)
Nutraceutical activation of Sirt1: a review (2022) (4)
The Aging Bowel Dysfunction and Elderly Vulnerability towards COVID-19 Infection (2021) (3)
Does elevated bilirubin aid weight control by preventing development of hypothalamic leptin resistance? (2019) (3)
Nutraceutical targeting of TLR4 signaling has potential for prevention of cancer cachexia. (2019) (3)
Could Carbohydrate-Concentrated Diets Mimic Calorie Restriction in Slowing the Aging Process ? (2012) (3)
A general strategy for the use of allogeneic lymphocyte infusions in the treatment of disorders characterized by impaired helper or suppressor T cell function: autoimmune diseases and the acquired immunodeficiency syndrome (AIDS). (1985) (3)
Peroxisome proliferators as adjuvants for the reverse-electron-transport therapy of obesity: an explanation for the large increase in metabolic rate of MEDICA 16-treated rats. (1999) (3)
Comparative analysis of phenolic content and antioxidant power between parasitic Phoradendron californicum (toji) and their hosts from Sonoran Desert (2020) (3)
Coenzyme Q10 deficiency can be expected to compromise Sirt1 activity (2022) (3)
A note on "orthomolecular aids for dieting"--myasthenic syndrome due to dl-carnitine. (1982) (3)
Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality (2017) (3)
Astaxanthin plus berberine: a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome (2019) (3)
NADPH oxidase, uncoupled endothelial nitric oxide synthase, and NF-KappaB are key mediators of the pathogenic impact of obstructive sleep apnea – Therapeutic implications (2016) (2)
Dietary fat and body composition. (1998) (2)
Concurrent administration of sustained-release bezafibrate may counteract the increased thrombotic risk associated with oral estrogen therapy. (2001) (2)
Hormonal and nutritional enhancement of Na+-K+-ATPase activity may aid the prevention and treatment of essential hypertension. (1984) (2)
Age-adjusted mortality from pancreatic cancer increased NINE-FOLD in japan from 1950 to 1995 - Was a low-protein quasi-vegan diet a key factor in their former low risk? (2021) (2)
Non-Occupational Cadmium Exposure is Emerging as a Major Cause of Cancer , Vascular Disorders , and Other Pathologies-A Long-term Controlled Trial of Supplementation with High-Dose Zinc , a Cadmium Antagonist , is Needed (2017) (2)
Up-regulation of hepatic IGFBP-1 production as a strategy for preventing benign prostatic hyperplasia. (2001) (2)
Monoselenolipoic acid may be an outstanding pharmaceutical antioxidant with direct thioredoxin-like activity. (2000) (2)
Co-administration of Phycocyanobilin and/or Phase 2-Inducer Nutraceuticals for Prevention of Opiate Tolerance. (2018) (2)
Nutraceutical Prevention of Diabetic Complications—Focus on Dicarbonyl and Oxidative Stress (2022) (2)
Full-Spectrum Antioxidant Therapy (2013) (2)
Nutritional modulation of mineralocorticoid and prostaglandin production: potential role in prevention and treatment of gastric pathology. (1983) (2)
Decreased magnesium status may mediate the increased cardiovascular risk associated with calcium supplementation (2017) (2)
Diet/Lifestyle Strategies for Preventing Benign Prostatic Hyperplasia (2014) (2)
High-dose biotin may down-regulate hepatic expression of acute phase reactants by mimicking the physiological role of nitric oxide. (2003) (2)
Interleukin-1beta may act on hepatocytes to boost plasma homocysteine - The increased cardiovascular risk associated with elevated homocysteine may be mediated by this cytokine. (2017) (2)
Non-toxic inhibition of extracellular tumor enzymes--potential in cancer therapy. (1982) (2)
Supplemental N-acetylcysteine and other measures that boost intracellular glutathione can downregulate interleukin-1β signalling: a potential strategy for preventing cardiovascular events? (2017) (2)
Optimized mitochondrial function as a nutritional strategy in cancer immunotherapy. (1981) (2)
Dietary fiber and weight gain. (2000) (1)
Plant-based Diets and Low-Insulin Lifestyles May Suppress Oxidative Stress By Disinhibiting FOXO3a (2011) (1)
The nutritionally and metabolically destructive "nutritional and metabolic antineoplastic diet" of laetrile proponents. (1980) (1)
Nutraceutical Strategies for Alleviation of UVB Phototoxicity. (2023) (1)
Nutraceutical Targeting of Placental Synthesis of Soluble Fms-Like Tyrosine Kinase- 1 (sFlt-1) as Strategy for Preventing and Controlling Pre-eclampsia. (2018) (1)
Addendum: Gamma-tocopherol, cox-2, and cancer risk. (2012) (1)
Overview of Macrophage Activating Factor and the Nagalase Assay – Potential for Control of Micrometastatic or Early Primary Cancer (2013) (1)
Chromium supplementation and iron metabolism. (1997) (1)
"Nutritional insurance" supplementation and corticosteroid toxicity. (1982) (1)
A PRACTICAL PRESCRIPTION FOR CANCER PREVENTION CHEMOPREVENTIVE AGENTS (1984) (1)
Integration of allogeneic lymphocyte immunotherapy with short-course chemotherapy and hypoenergic hyperthermia: a "triple-threat" treatment for disseminated cancer. (1985) (1)
The A54T polymorphism of fatty acid-binding protein 2 may entail a reduction in fat-stimulated secretion of GIP that potentiates the adverse impact of fatty diets on insulin sensitivity. (2003) (1)
Tributyrin May Have Practical Potential for Improving Cognition in Early Alzheimer ’ s Disease Via Inhibition of HDAC 2 (2013) (1)
Calcium supplementation, renin, and vascular risk (2012) (1)
Isoflavones Made Simple – Agonist Activity for the Beta-Type Estrogen Receptor May Mediate Their Health Benefits (2009) (1)
Management of acute myocardial infarction with natural physiological agents. (1983) (1)
Hypothesis: Spirulina may Slow the Growth and Spread of Ovarian Cancer byInterfering with Growth Factor Activity of Lysophophatidic Acid (2015) (1)
Common pathologic pathways: a single prescription dream? (2012) (1)
ACTIVATION OF NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (NADPH) OXIDASE (NOX) BY TYPE 1 RECEPTORS FOR ANGIOTENSIN II (ATII) (2015) (1)
Marinobufagenin may mediate the adverse impact of salty diets on renal calcium retention by impairing the efficiency of renal tubular sodium-calcium exchange. (2005) (1)
NADPH Oxidase Activity in Retinal Pigmented Epithelium as a Target for Prevention of Age-related Macular Degeneration (2017) (1)
Chromium picolinate may favorably influence the vascular risk associated with smoking by combating cortisol-induced insulin resistance. (2005) (1)
RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. (2014) (1)
Downregulation of Macrophage Activation by PPARγ Suggests a Role for Conjugated Linoleic Acid in Prevention of Alzheimer's Disease and Atherosclerosis (1998) (1)
A Key Role for Activation of Chondrocyte NADPH Oxidase in the Loss of Cartilage Matrix Associated with Osteoarthritis (2008) (0)
Thymoquinone and Melatonin Boost Both Sirt1 and Nrf2 Activities in a Complementary Way – A Strategy for Controlling Oxidative Stress and Inflammation (2022) (0)
Marinobufagenin may mediate the impact of salty diets on left ventricular hypertrophy by disrupting the protective function of coronary microvascular endothelium. (2005) (0)
A Role for Activated Microglia and Peroxynitrite in Lewy Body Diseases – Implications for Prevention and Control (2012) (0)
Roles of Oxidative Stress in the Pathogenesis of Hepatitis C – Implications for Full-Spectrum Antioxidant Therapy with Phlebotomy (2012) (0)
Angiotensin antagonist drugs as "source antioxidants" - Down- regulation of nicotinamide adenine dinucleotide phosphate oxidase activation mediates many of their protective benefits, independent of hypertension control (2015) (0)
Phycobilins Inhibit NADPH Oxidase – A Personal Perspective on the Discovery (2010) (0)
A Carbohydrate Concentration Regimen that Segregates Protein-Rich Foods into Low-Carb Meals May Represent a More Practical Way to Achieve the Healthspan Benefits Conferred by Calorie Restriction or Alternate-Day Fasting (2013) (0)
Stroke Prevention in a Nutshell (2013) (0)
Targeting Oxidant Stress as a Strategy for Preventing Vascular Complications of Diabetes and Metabolic Syndrome (2009) (0)
Managing obesity – no need for nihilism (2001) (0)
Dietary L-Arginine Attenuates Blood Pressure in Mineralocorticoid-Salt Hypertensive Rats " , Clin . and Exper (2017) (0)
Age-Related Macular Degeneration – Potential Roles for Nutraceuticals in its Prevention and Control (2012) (0)
NADPH Oxidase May be the Primary Mediator of Organic Erectile Dysfunction (2008) (0)
Adjuvants of Potential Value in Multiple Myeloma Treatment (2012) (0)
Adjuvant Melanoma Treatment Strategies (2012) (0)
Nutraceutical and Dietary Resources for Breast Cancer Prevention – Highlighting Strategies for Suppressing Breast Aromatase Expression (2022) (0)
Addiction of Prostate Cancer Beyond Androgen Deprivation : Ancillary Integrative Strategies for Targeting the Androgen Receptor (2014) (0)
Spirulina Rising: The Application of Microalgae in Protecting Human Health and Treating Disease (2019) (0)
β-Boswellic Acid , A Safe and Clinically Effective Inhibitor of Prostaglandin E Synthase-1 , Has Potential for Prevention of Cancer , Alzheimer ’ s Disease , and Vascular Disorders , and for Control of Inflammatory Pain (2013) (0)
Maintaining Effective Beta Cell Function in the Face of Metabolic Syndrome-Associated Glucolipotoxicity—Nutraceutical Options (2021) (0)
ALTERNATIVE MEDICINE Spirulina Rising: Microalgae, Phyconutrients, and Oxidative Stress (2019) (0)
Memo : Is Peroxynitrite a Mediator of Survival and Aggressive Growth in Pancreatic Adenocarcinoma ? (2013) (0)
Spirulina Rising : A Foundation in Microalgal Phyconutrients (2021) (0)
An increased need for dietary cysteine in support of glutathione synthesis may underlie the increased risk for mortality associated with low protein intake in the elderly (2015) (0)
Spirulina Rising : PhyCB , Treg Induction , and AST (2019) (0)
Tripicolinate chromique a haute dose servant au traitement du diabete de type ii (1996) (0)
Adjuvant Pancreatic Cancer Treatment Strategies (2012) (0)
A Key Role for HIV-1-Activated NADPH Oxidase in the Pathogenesis of AIDS (2010) (0)
Minimizing the Contribution of Oxidative Stress to Disease and Aging (2010) (0)
Epithelial Ovarian Cancer – Adjuvant Measures with Potential for Slowing Its Spread and Boosting or Restoring its Chemosensitivity (2012) (0)
Erratum to “cGMP may have trophic effects on beta cell function comparable to those of cAMP, implying a role for high-dose biotin in prevention/treatment of diabetes [Med Hypotheses 66 (2005) 323–328]” (2006) (0)
Could zinc dipicolinate be used to “smuggle” zinc into prostate cancer cells? (2020) (0)
Genistein , Phycocyanobilin , and Melatonin May Prevent Hepatic Fibrosis by Suppressing Proliferation and Activation of Hepatic Stellate Cells (2008) (0)
The Favorable Impact of Statins on Risk for Deep Vein Thrombosis May Reflect a Down-Regulation of NADPH Oxidase Activity that Suppresses Hypoxia-Mediated Activation of Venular Endothelium and Monocyte Tissue Factor Expression (2010) (0)
Nutraceutical Aid for Allergies – Strategies for Down-Regulating Mast Cell Degranulation (2021) (0)
AMPK activation—protean potential for boosting healthspan (2013) (0)
Practical Strategies for Preserving Good Cognitive Function into Old Age (2013) (0)
RAC PROTEIN AND METHOD OF SCREENING THE SAME (2017) (0)
Rationale for a Novel Nutraceutical Complex : Potassium Taurine Bicarbonate (2013) (0)
The Japanese Experience Suggests that Lethal Prostate Cancer is Almost Wholly Preventable with a Quasi-Vegan Diet, Soy Products, and Green Tea (2022) (0)
Ketosis May Promote Brain Macroautophagy via Activation of Hypoxia-Inducible Factor-1 (2012) (0)
OVER-THE-COUNTER CHROMIUM AND RENAL FAILURE. AUTHOR'S REPLY (1997) (0)
Patent Number : 5 , 776 , 504 45 ) Date of Patent : Jul . 7 , 1998 (2017) (0)

This paper list is powered by the following services:

Mark Frederick Mccarty's Academic­Influence.com Rankings

Why Is Mark Frederick Mccarty Influential?

Mark Frederick Mccarty's Published Works

Published Works

Mark Frederick Mccarty's AcademicInfluence.com Rankings